Acetaminophen is a non-narcotic analgesic, antipyretic, weak anti-inflammatory activity. COX-3 in...
-
Upload
jacob-welch -
Category
Documents
-
view
215 -
download
0
Transcript of Acetaminophen is a non-narcotic analgesic, antipyretic, weak anti-inflammatory activity. COX-3 in...
PRACTICAL TOXICOLOGY CASES
ACETAMINOPHENTOXICITY
Acetaminophen is a non-narcotic analgesic, antipyretic, weak anti-inflammatory activity.
Class
• COX-3 in CNS PGs (brain)Pyrogen PG temp. regulatory centres hyperthermias. • COX-1 & COX-2 in periphery (mild effect)
Therapeutic mechanism of action
• Peptic ulcer.• Bronchial asthma.• Viral infection in children. (Aspirin may lead to Reye’s
syndrome (hepatic encephalopathy)).
Indications for preferential use of acetaminophen
• Toxic dose: more than 7.5g as a single dose• Hepatotoxic dose: starts at 140 mg/kg
Doses
Acetaminophen metabolism
ROSBind with
macromolecules in liver cells (lipid, protein, DNA)
necrosisChandok N , Watt K D S Mayo Clin Proc. 2010;85:451-458
GSHMercapturic acid and cysteine conjugates
STAGE I: (6-24 HRS)Non specific symptoms: a) Anorexia, malaise b) Nausea, vomiting c) Diaphoresis
Symptoms may persist for up to 24 hrs.
STAGE II: (24-48 HRS)• State of well being• AST & ALT disturbance in liver function.• Prolonged prothrombin time. • Patient may complain from right upper quadrant
tenderness & the liver may be enlarged.
Stages of Toxicity
STAGE III: (3-5 DAYS) (Liver necrosis)
1. Hypoglycaemia: glycogenolysis & gluconeogenesis2. Metabolic acidosis:
lipolysis (TG FFA acetyl co A ketone bodies)3. Hyperbilirubinemia:
a. Disturbance in uptake of bilirubin from blood to liver so in blood .b secretion of conjugated bilirubin from liver to extra hepatic bile
duct4. Lethargy5. Coma6. Coagulopathy: prothrombin time & bleeding.7. Renal failure:8. Formation of NAPQI in kidney (rich in Cyt P450 ) depletion of GSH
NAPQI Renal injury
Death is a result of complications associated with hepatic failure
Stages of Toxicity
STAGE IV: (7-8 DAYS)
• During this stage recovery occurs• The serum enzymes return to normal, but hepatic
necrosis persist
In which stage the patient appear normal? (II,IV)In which stage the liver disturbance starts? (II)
Stages of Toxicity
Severe liver damage that might necessitate LIVER transplantation can be suspected in the following cases:
1. Severe acidosis (pH <7.3)
2. Prothrombin time > 50s (USA) or 100s (UK)
3. Grade III/IV hepatic encephalopathy
4. Serum creatinine > 3.3 mg/dL (300mM/L)
5. Bilirubin > 4mg/dL
Poor Prognosis
1. GUT DECONTAMINATION: (1-4 hrs after ingestion)
• Emesis: but not used if vomiting, coma, permanent emesis• Gastric lavage: put the patient on his left side.• Activated charcoal: 1-2g/kg
2. ANTIDOTE: (within 8-14 hrs)
• Must be taken within 8 hrs to prevent liver necrosis• N-acetylcysteine:
a. Directly binds with NAPQI.b. Source for GSH (GSH precursor)
(N-acetylcysteine cysteine GSH inhibit NAPQI)
Management
ManagementN-acetylcysteine: (continued)
• Types: I.V (Parvolex) - Oral (Mucomyst) Parvolex is only allowed in UK as it may cause anaphylactic shock
• Dose:a. Loading dose: N-acetylcysteine is 140 mg/kg. It must be
diluted to a 5% conc with Cola or fruit juice. After 1 hr give maintenance dose
b. Maintenance dose: 17 doses of 70 mg/kg every 4hrs
E.g.: 140mg/kg 140 mg 1 kg X mg 50 kg X = 7000mg = 7gm 5 gm 100ml 7 gm Y Y = 140 ml
ManagementN-acetylcysteine: (continued)
• In case of persistent vomiting:The patient can’t receive oral antidotal treatment, so metoclopramide (1mg/kg I.V.) is given. If this failed, ondansetron (0.15mg/kg) is given to stop the vomiting before ttt with the antidote is ensued.
3. ENHANCED ELIMINATION:
• This is done by exchange transfusion (complete blood replacement)
• Successful in the following cases:1. Patients who didn’t receive antidote within 15 hrs from
intoxication2. Patients at risk of severe liver damage3. ALT/AST levels > 5000 U/L
Assessment of Toxicity
How could you overcome the administration of giving antidote with activated charcoal? Remove activated charcoal first by gastric lavage before
administration of antidote. dose of antidote by 30 - 40%
In some conditions, although the amount of acetaminophen in plasma is less than the toxic threshold in nomogram, the patient may suffer from hepatotoxicity, why? Chronic alcoholism: Cyt P450 NAPQI Malnutrition: GSH
Why is acetaminophen toxicity less likely to occur with children? Acetaminophen overdose induction vomiting. Metabolic system is sulfation, (acetaminophen inactive) Cyt P450 not well developed, turn over of GSH is very high
Keep in mind the following
Case Study
W.R. is a 40-year old, 75 kg alcoholic male brought to the
emergency department six hours after ingesting fifty 500 mg
acetaminophen tablets. At home, he was given syrup of ipecac to
induce emesis, but no undissolved tablets were seen. The
patient’s only complaints were nausea, vomiting, and anorexia. He
was given an oral dose of activated charcoal 60gm and
magnesium citrate 300mL. Physical examination was
unremarkable; a blood sample for measurement of the
acetaminophen serum concentration was obtained.
Case StudyWhat are the symptoms of acetaminophen poisoning? Were W.R.
symptoms consistent with an acute intoxication?
• Symptoms: (see stages I-IV)
• The symptoms are consistent with acute intoxication as the
patient suffered from stage I symptoms (nausea, vomiting, and
anorexia)
Case StudyDescribe the mechanism(s) of acetaminophen-induced hepatotoxicity and assess W.R. risk for the development of this complication.
• Mechanisms: (see NAPQI formation)
• W.R. ingested 330 mg/kg of acetaminophen ((50 X 500)/75). • Ingestions of this magnitude are usually associated with hepatic
necrosis, if antidotal treatment is not initiated or is delayed. • If W.R.’s serum concentration was less than 120 mg/ml four to six
hours after ingestion, his risk for development of hepatic necrosis would be estimated as minimal by the nomogram.
• However, hepatotoxicity has been reported in alcoholics after repeated therapeutic doses of acetaminophen and hepatotoxicity could occur in W.R. even with a reportedly “safe” serum concentration.
• Alcoholics appear to be at increased risk for acetaminophen-induced hepatotoxicity, because an alcohol-induced cytochrome P450 mixed-function oxidase system results in increased formation of the reactive intermediate.
• Also, alcohol-associated malnutrition can result in decreased hepatic glutathione stores.
Case StudyThe acetaminophen serum concentration obtained on admission
was 295 mg/mL. What additional treatment is indicated for W R.?
The patient should immediately receive an antidotal treatment and
should be closely monitored for possible application of enhanced
elimination techniques.